Videos

The Distinct Pharmacology of ZEJULA

The following videos describe the unique pharmacologic profile of ZEJULA. View them now to learn more about the therapeutic rationale behind PARP inhibition and aspects of how ZEJULA behaves in the body.

Volume of Distribution
Volume of Distribution
Bioavailability
Bioavailability
Intro to PARP Inhibition
Intro to PARP Inhibition
Permeability
Permeability
Important Safety Information
Important Safety Information
Conclusion
Conclusion
Selectivity
Selectivity
Half-Life
Half-Life
Video thumbnail: Watch this video to learn about the effectiveness of PARP inhibitors in difficult-to-treat BRCAwt patients
WildType
Pivotal trial

PIVOTAL NOVA TRIAL

See the NOVA clinical phase 3 trial

View the Trial
Considerations for dose modification

"WEIGHTS AND PLATES" ANALYSIS

Identify patients likely to require early dose modification

See the Data
Back to Top